Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,225,239
-$719,666 QoQ
Shares Held
65,104
+1.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#468
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cresset Asset Management, LLC holds $338,415,690 across 14 Drug Manufacturers - General names. GILD ranks #10 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
336,570 | $85,478,682 | |
| 2 | LLY |
ELI LILLY & Co
|
59,006 | $70,773,572 | |
| 3 | ABBV |
AbbVie Inc.
|
190,827 | $48,019,706 | |
| 4 | MRK |
Merck & Co., Inc.
|
271,475 | $34,884,537 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
417,663 | $24,065,742 | |
| 6 | AMGN |
Amgen Inc
|
47,883 | $17,339,391 | |
| 7 | NVS |
Novartis AG
|
104,792 | $16,423,002 | |
| 8 | PFE |
Pfizer Inc
|
634,638 | $15,282,083 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,225,239 | 65,104 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,944,905 | 64,181 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,580,299 | 61,759 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,400,260 | 57,660 | Shares | Sole | 2026-01-22 | |
| 2025-06-30 | $5,967,466 | 53,824 | Shares | Sole | 2026-01-22 | |
| 2025-03-31 | $6,917,518 | 61,736 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,108,240 | 76,954 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,712,239 | 151,625 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,755,458 | 127,612 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,025,919 | 95,917 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,696,031 | 95,001 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,752,318 | 90,103 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,486,656 | 97,141 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,508,809 | 18,185 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,866,464 | 21,741 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,398,142 | 22,664 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,518,548 | 24,568 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,490,708 | 25,075 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,939,906 | 40,489 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,834,792 | 40,584 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,306,121 | 33,490 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,495,732 | 23,143 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,192,232 | 20,464 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,587,080 | 25,116 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,072,686 | 26,939 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $1,413,263 | 18,904 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||